Global Human Bacterial Vaccine Market Growth (Status and Outlook) 2022-2028
- LP 4911748
- 85 Pages
- March 2022
- Pharmaceuticals
The United States Human Bacterial Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Bacterial Vaccine market, reaching US$ million by the year 2028. As for the Europe Human Bacterial Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Human Bacterial Vaccine players cover Merck, Sanofi, GSK, and Mitsubishi Tanabe Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Bacterial Vaccine market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Clostridium Tetani
Pertussis
Haemophilus Influenzae
Streptococcus Pneumoniae
Salmonella Typhi
Bacillus Anthracis
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Children
Adults
Elderly
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Merck
Sanofi
GSK
Mitsubishi Tanabe Pharma
Pfizer
Bayer
Emergent BioSolutions
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Bacterial Vaccine Market Size 2017-2028
2.1.2 Human Bacterial Vaccine Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Human Bacterial Vaccine Segment by Type
2.2.1 Clostridium Tetani
2.2.2 Pertussis
2.2.3 Haemophilus Influenzae
2.2.4 Streptococcus Pneumoniae
2.2.5 Salmonella Typhi
2.2.6 Bacillus Anthracis
2.2.7 Others
2.3 Human Bacterial Vaccine Market Size by Type
2.3.1 Human Bacterial Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Human Bacterial Vaccine Market Size Market Share by Type (2017-2022)
2.4 Human Bacterial Vaccine Segment by Application
2.4.1 Children
2.4.2 Adults
2.4.3 Elderly
2.5 Human Bacterial Vaccine Market Size by Application
2.5.1 Human Bacterial Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Human Bacterial Vaccine Market Size Market Share by Application (2017-2022)
3 Human Bacterial Vaccine Market Size by Player
3.1 Human Bacterial Vaccine Market Size Market Share by Players
3.1.1 Global Human Bacterial Vaccine Revenue by Players (2020-2022)
3.1.2 Global Human Bacterial Vaccine Revenue Market Share by Players (2020-2022)
3.2 Global Human Bacterial Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Human Bacterial Vaccine by Regions
4.1 Human Bacterial Vaccine Market Size by Regions (2017-2022)
4.2 Americas Human Bacterial Vaccine Market Size Growth (2017-2022)
4.3 APAC Human Bacterial Vaccine Market Size Growth (2017-2022)
4.4 Europe Human Bacterial Vaccine Market Size Growth (2017-2022)
4.5 Middle East & Africa Human Bacterial Vaccine Market Size Growth (2017-2022)
5 Americas
5.1 Americas Human Bacterial Vaccine Market Size by Country (2017-2022)
5.2 Americas Human Bacterial Vaccine Market Size by Type (2017-2022)
5.3 Americas Human Bacterial Vaccine Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Bacterial Vaccine Market Size by Region (2017-2022)
6.2 APAC Human Bacterial Vaccine Market Size by Type (2017-2022)
6.3 APAC Human Bacterial Vaccine Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Human Bacterial Vaccine by Country (2017-2022)
7.2 Europe Human Bacterial Vaccine Market Size by Type (2017-2022)
7.3 Europe Human Bacterial Vaccine Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Bacterial Vaccine by Region (2017-2022)
8.2 Middle East & Africa Human Bacterial Vaccine Market Size by Type (2017-2022)
8.3 Middle East & Africa Human Bacterial Vaccine Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Human Bacterial Vaccine Market Forecast
10.1 Global Human Bacterial Vaccine Forecast by Regions (2023-2028)
10.1.1 Global Human Bacterial Vaccine Forecast by Regions (2023-2028)
10.1.2 Americas Human Bacterial Vaccine Forecast
10.1.3 APAC Human Bacterial Vaccine Forecast
10.1.4 Europe Human Bacterial Vaccine Forecast
10.1.5 Middle East & Africa Human Bacterial Vaccine Forecast
10.2 Americas Human Bacterial Vaccine Forecast by Country (2023-2028)
10.2.1 United States Human Bacterial Vaccine Market Forecast
10.2.2 Canada Human Bacterial Vaccine Market Forecast
10.2.3 Mexico Human Bacterial Vaccine Market Forecast
10.2.4 Brazil Human Bacterial Vaccine Market Forecast
10.3 APAC Human Bacterial Vaccine Forecast by Region (2023-2028)
10.3.1 China Human Bacterial Vaccine Market Forecast
10.3.2 Japan Human Bacterial Vaccine Market Forecast
10.3.3 Korea Human Bacterial Vaccine Market Forecast
10.3.4 Southeast Asia Human Bacterial Vaccine Market Forecast
10.3.5 India Human Bacterial Vaccine Market Forecast
10.3.6 Australia Human Bacterial Vaccine Market Forecast
10.4 Europe Human Bacterial Vaccine Forecast by Country (2023-2028)
10.4.1 Germany Human Bacterial Vaccine Market Forecast
10.4.2 France Human Bacterial Vaccine Market Forecast
10.4.3 UK Human Bacterial Vaccine Market Forecast
10.4.4 Italy Human Bacterial Vaccine Market Forecast
10.4.5 Russia Human Bacterial Vaccine Market Forecast
10.5 Middle East & Africa Human Bacterial Vaccine Forecast by Region (2023-2028)
10.5.1 Egypt Human Bacterial Vaccine Market Forecast
10.5.2 South Africa Human Bacterial Vaccine Market Forecast
10.5.3 Israel Human Bacterial Vaccine Market Forecast
10.5.4 Turkey Human Bacterial Vaccine Market Forecast
10.5.5 GCC Countries Human Bacterial Vaccine Market Forecast
10.6 Global Human Bacterial Vaccine Forecast by Type (2023-2028)
10.7 Global Human Bacterial Vaccine Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Human Bacterial Vaccine Product Offered
11.1.3 Merck Human Bacterial Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Human Bacterial Vaccine Product Offered
11.2.3 Sanofi Human Bacterial Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Human Bacterial Vaccine Product Offered
11.3.3 GSK Human Bacterial Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Mitsubishi Tanabe Pharma
11.4.1 Mitsubishi Tanabe Pharma Company Information
11.4.2 Mitsubishi Tanabe Pharma Human Bacterial Vaccine Product Offered
11.4.3 Mitsubishi Tanabe Pharma Human Bacterial Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Mitsubishi Tanabe Pharma Main Business Overview
11.4.5 Mitsubishi Tanabe Pharma Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Human Bacterial Vaccine Product Offered
11.5.3 Pfizer Human Bacterial Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Bayer
11.6.1 Bayer Company Information
11.6.2 Bayer Human Bacterial Vaccine Product Offered
11.6.3 Bayer Human Bacterial Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bayer Main Business Overview
11.6.5 Bayer Latest Developments
11.7 Emergent BioSolutions
11.7.1 Emergent BioSolutions Company Information
11.7.2 Emergent BioSolutions Human Bacterial Vaccine Product Offered
11.7.3 Emergent BioSolutions Human Bacterial Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Emergent BioSolutions Main Business Overview
11.7.5 Emergent BioSolutions Latest Developments
12 Research Findings and Conclusion
Table 1. Human Bacterial Vaccine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Clostridium Tetani
Table 3. Major Players of Pertussis
Table 4. Major Players of Haemophilus Influenzae
Table 5. Major Players of Streptococcus Pneumoniae
Table 6. Major Players of Salmonella Typhi
Table 7. Major Players of Bacillus Anthracis
Table 8. Major Players of Others
Table 9. Human Bacterial Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Human Bacterial Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 11. Global Human Bacterial Vaccine Market Size Market Share by Type (2017-2022)
Table 12. Human Bacterial Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global Human Bacterial Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 14. Global Human Bacterial Vaccine Market Size Market Share by Application (2017-2022)
Table 15. Global Human Bacterial Vaccine Revenue by Players (2020-2022) & ($ Millions)
Table 16. Global Human Bacterial Vaccine Revenue Market Share by Player (2020-2022)
Table 17. Human Bacterial Vaccine Key Players Head office and Products Offered
Table 18. Human Bacterial Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Human Bacterial Vaccine Market Size by Regions 2017-2022 & ($ Millions)
Table 22. Global Human Bacterial Vaccine Market Size Market Share by Regions (2017-2022)
Table 23. Americas Human Bacterial Vaccine Market Size by Country (2017-2022) & ($ Millions)
Table 24. Americas Human Bacterial Vaccine Market Size Market Share by Country (2017-2022)
Table 25. Americas Human Bacterial Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 26. Americas Human Bacterial Vaccine Market Size Market Share by Type (2017-2022)
Table 27. Americas Human Bacterial Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 28. Americas Human Bacterial Vaccine Market Size Market Share by Application (2017-2022)
Table 29. APAC Human Bacterial Vaccine Market Size by Region (2017-2022) & ($ Millions)
Table 30. APAC Human Bacterial Vaccine Market Size Market Share by Region (2017-2022)
Table 31. APAC Human Bacterial Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 32. APAC Human Bacterial Vaccine Market Size Market Share by Type (2017-2022)
Table 33. APAC Human Bacterial Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 34. APAC Human Bacterial Vaccine Market Size Market Share by Application (2017-2022)
Table 35. Europe Human Bacterial Vaccine Market Size by Country (2017-2022) & ($ Millions)
Table 36. Europe Human Bacterial Vaccine Market Size Market Share by Country (2017-2022)
Table 37. Europe Human Bacterial Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 38. Europe Human Bacterial Vaccine Market Size Market Share by Type (2017-2022)
Table 39. Europe Human Bacterial Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 40. Europe Human Bacterial Vaccine Market Size Market Share by Application (2017-2022)
Table 41. Middle East & Africa Human Bacterial Vaccine Market Size by Region (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Human Bacterial Vaccine Market Size Market Share by Region (2017-2022)
Table 43. Middle East & Africa Human Bacterial Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Human Bacterial Vaccine Market Size Market Share by Type (2017-2022)
Table 45. Middle East & Africa Human Bacterial Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 46. Middle East & Africa Human Bacterial Vaccine Market Size Market Share by Application (2017-2022)
Table 47. Key Market Drivers & Growth Opportunities of Human Bacterial Vaccine
Table 48. Key Market Challenges & Risks of Human Bacterial Vaccine
Table 49. Key Industry Trends of Human Bacterial Vaccine
Table 50. Global Human Bacterial Vaccine Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 51. Global Human Bacterial Vaccine Market Size Market Share Forecast by Regions (2023-2028)
Table 52. Global Human Bacterial Vaccine Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 53. Global Human Bacterial Vaccine Market Size Market Share Forecast by Type (2023-2028)
Table 54. Global Human Bacterial Vaccine Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 55. Global Human Bacterial Vaccine Market Size Market Share Forecast by Application (2023-2028)
Table 56. Merck Details, Company Type, Human Bacterial Vaccine Area Served and Its Competitors
Table 57. Merck Human Bacterial Vaccine Product Offered
Table 58. Merck Human Bacterial Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 59. Merck Main Business
Table 60. Merck Latest Developments
Table 61. Sanofi Details, Company Type, Human Bacterial Vaccine Area Served and Its Competitors
Table 62. Sanofi Human Bacterial Vaccine Product Offered
Table 63. Sanofi Main Business
Table 64. Sanofi Human Bacterial Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Sanofi Latest Developments
Table 66. GSK Details, Company Type, Human Bacterial Vaccine Area Served and Its Competitors
Table 67. GSK Human Bacterial Vaccine Product Offered
Table 68. GSK Main Business
Table 69. GSK Human Bacterial Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. GSK Latest Developments
Table 71. Mitsubishi Tanabe Pharma Details, Company Type, Human Bacterial Vaccine Area Served and Its Competitors
Table 72. Mitsubishi Tanabe Pharma Human Bacterial Vaccine Product Offered
Table 73. Mitsubishi Tanabe Pharma Main Business
Table 74. Mitsubishi Tanabe Pharma Human Bacterial Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Mitsubishi Tanabe Pharma Latest Developments
Table 76. Pfizer Details, Company Type, Human Bacterial Vaccine Area Served and Its Competitors
Table 77. Pfizer Human Bacterial Vaccine Product Offered
Table 78. Pfizer Main Business
Table 79. Pfizer Human Bacterial Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Pfizer Latest Developments
Table 81. Bayer Details, Company Type, Human Bacterial Vaccine Area Served and Its Competitors
Table 82. Bayer Human Bacterial Vaccine Product Offered
Table 83. Bayer Main Business
Table 84. Bayer Human Bacterial Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Bayer Latest Developments
Table 86. Emergent BioSolutions Details, Company Type, Human Bacterial Vaccine Area Served and Its Competitors
Table 87. Emergent BioSolutions Human Bacterial Vaccine Product Offered
Table 88. Emergent BioSolutions Main Business
Table 89. Emergent BioSolutions Human Bacterial Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Emergent BioSolutions Latest Developments
List of Figures
Figure 1. Human Bacterial Vaccine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Bacterial Vaccine Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Human Bacterial Vaccine Market Size Market Share by Type in 2021
Figure 7. Human Bacterial Vaccine in Children
Figure 8. Global Human Bacterial Vaccine Market: Children (2017-2022) & ($ Millions)
Figure 9. Human Bacterial Vaccine in Adults
Figure 10. Global Human Bacterial Vaccine Market: Adults (2017-2022) & ($ Millions)
Figure 11. Human Bacterial Vaccine in Elderly
Figure 12. Global Human Bacterial Vaccine Market: Elderly (2017-2022) & ($ Millions)
Figure 13. Global Human Bacterial Vaccine Market Size Market Share by Application in 2021
Figure 14. Global Human Bacterial Vaccine Revenue Market Share by Player in 2021
Figure 15. Global Human Bacterial Vaccine Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Human Bacterial Vaccine Market Size 2017-2022 ($ Millions)
Figure 17. APAC Human Bacterial Vaccine Market Size 2017-2022 ($ Millions)
Figure 18. Europe Human Bacterial Vaccine Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Human Bacterial Vaccine Market Size 2017-2022 ($ Millions)
Figure 20. Americas Human Bacterial Vaccine Value Market Share by Country in 2021
Figure 21. Americas Human Bacterial Vaccine Consumption Market Share by Type in 2021
Figure 22. Americas Human Bacterial Vaccine Market Size Market Share by Application in 2021
Figure 23. United States Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Human Bacterial Vaccine Market Size Market Share by Region in 2021
Figure 28. APAC Human Bacterial Vaccine Market Size Market Share by Application in 2021
Figure 29. China Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Human Bacterial Vaccine Market Size Market Share by Country in 2021
Figure 36. Europe Human Bacterial Vaccine Market Size Market Share by Type in 2021
Figure 37. Europe Human Bacterial Vaccine Market Size Market Share by Application in 2021
Figure 38. Germany Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Human Bacterial Vaccine Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Human Bacterial Vaccine Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Human Bacterial Vaccine Market Size Market Share by Application in 2021
Figure 46. Egypt Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Human Bacterial Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 52. APAC Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 53. Europe Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 55. United States Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 56. Canada Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 59. China Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 60. Japan Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 61. Korea Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 63. India Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 64. Australia Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 65. Germany Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 66. France Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 67. UK Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 68. Italy Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 69. Russia Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 70. Spain Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 73. Israel Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Human Bacterial Vaccine Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
